STAAR Surgical (NASDAQ:STAA) reported its Q4 2024 earnings, revealing a significant miss on both earnings per share (EPS) and revenue compared to forecasts. The company posted an EPS of -$0.69, far ...
Chairman and CEO James Quincey highlighted a 7% comparable EPS growth for 2024, despite challenges such as double-digit currency headwinds and bottler refranchising. He noted robust organic revenue ...
Chip export controls were supposed to prevent China from rivaling U.S.-based gen AI. DeepSeek got around that, and tougher rules may not do much better.
Small modular reactors present potential advantages in safety, cost and a broader range of applications than traditional nuclear reactors, and could play a key role in the energy transition. But the ...
The incoming U.S. administration poses significant challenges, with repercussions extending beyond bilateral relations with China. Finding the proper balance between international exchanges and ...